SavedAdd your journal

Journals / Çocuk Dergisi / 2022 / Cilt: 22 - Sayı: 2

Antiepileptic Drugs in Children

Çocuklarda Antiepileptik İlaçlar

Burçin Nazlı KARACABEY
Edibe PEMBEGÜL YILDIZ
Mine ÇALIŞKAN
Pages
117–123
Publication Date
2022-09-09
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, many current sources are examined, and the mechanisms of action, pharmacokinetic properties, clinical use and doses, side effects and drug interactions of AEDs that are frequently used in children are discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Antiepileptic drugs (AEDs) lead to seizure freedom in about 70% of all children with epilepsy.
📊
Key Findings & Data:Appropriate drug selection is determined by the patient’s age, seizure semiology, epileptic syndrome, and pharmacogenetic approach.
💡
Conclusion & Impact:In this review, many current sources are examined, and the mechanisms of action, pharmacokinetic properties, clinical use and doses, side effects and drug interactions of AEDs that are frequently used in children are discussed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Antiepileptik ilaçlar · çocuklar · epilepsi

Abstract

Antiepileptic drugs (AEDs) lead to seizure freedom in about 70% of all children with epilepsy. Appropriate drug selection is determined by the patient’s age, seizure semiology, epileptic syndrome, and pharmacogenetic approach. The aim of treatment is to prevent seizures by maintaining the effective dose of one or more antiepileptic drugs. In recent years, many new generation AEDs with less side-effect profiles and drug interactions have been used in clinical practice. The clinical uses and side effects of AEDs are different in children than adults. The characteristics of AEDs in the pediatric age group are extremely important in the success of treatment. In this review, many current sources are examined, and the mechanisms of action, pharmacokinetic properties, clinical use and doses, side effects and drug interactions of AEDs that are frequently used in children are discussed.

Özet

Antiepileptik ilaçlar (AEİ) ile epilepsi tanılı çocukların yaklaşık %70’nde nöbetler kontrol altına alınır. Seçilecek ilaç hastaların yaşı, nöbet semiyolojisi, epileptik sendrom, farmakogenetik yaklaşım ile belirlenir. Tedavide amaç bir veya daha fazla antiepileptik ilacın etkili dozunu muhafaza ederek nöbet oluşumunu önlemektir. Son yıllarda yan etki profili ve ilaç etkileşimi daha az olan birçok yeni nesil AEİ gündeme gelmiş olup bir kısmı klinik pratikte kullanılmaktadır. Çocuklarda, erişkinlere göre AEİ’lerin klinik kullanımları ve yan etkileri farklıdır. AEİ’lerin çocuk yaş grubuna ait özelliklerinin bilinmesi tedavi başarısında son derece önemlidir. Derlememizde çok sayıda güncel kaynak incelenerek çocukluklarda sık kullanılan AEİ’lerin etki mekanizmaları, farmakokinetik özellikleri, klinik kullanım ve dozları, yan etki ve ilaç etkileşimleri ele alınmıştır.

🔖

Cite This Article

KARACABEY, B. N., YILDIZ, E. P., ÇALIŞKAN, M. (2022). Antiepileptic Drugs in Children. Çocuk Dergisi, Cilt: 22 - Sayı: 2, 117–123. https://ajindex.com/articles/715323

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Sillanpaa M, Saarinen M, Schmidt D. Clinical conditions of long-term cure in childhood-onset epilepsy: a 45-year follow-up study. Epilepsy Behav 2014
  2. google scholar 2. LaPenna P, Tormoehlen LM. The Pharmacology and Toxicology of Third-Generation Anticonvulsant Drugs. J Med Toxicol 2017
  3. google scholar 3. V. Singh KP, Verma N. Teratogenic potential of third-generation antiepileptic drugs: Current status and research needs. Pharmacol Rep 2019
  4. google scholar 4. Davies JA. Mechanisms of action of antiepileptic drugs. Seizure 1995
  5. google scholar 5. Kobayashi K, Endoh F, Ohmori I, Akiyama T. Action of antiepileptic drugs on neurons. Brain Dev 2020
  6. google scholar 6. Heimann G, Gladtke E. Pharmacokinetics of phenobarbital in childhood. Eur J Clin Pharmacol 1977
  7. google scholar 7. Nicholas SA, Frances EJ, Terrie EI, Joseph JV. Volpe’s Neurology of the Newborn. 6th ed. Elsevier 2018
  8. google scholar 8. Favie LMA, Groenendaal F, van den Broek MPH, Rademaker CMA, de Haan TR, van Straaten HLM et al. Phenobarbital, Midazolam Pharmacokinetics, Effectiveness, and Drug-Drug Interaction in Asphyxiated Neonates Undergoing Therapeutic Hypothermia. Neonatology 2019
  9. google scholar 9. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T et al. Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012
  10. google scholar 10. Arif H, Buchsbaum R, Weintraub D, Koyfman S, Salas-Humara C, Bazil CW. Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology 2007
  11. ,1701-9. google scholar 11. Abou-Khalil BW. Update on Antiepileptic Drugs 2019. Continuum 2019
  12. google scholar 12. Patsalos PN, St Louis EK. The Epilepsy Prescriber’s Guide to Antiepileptic Drugs. 3rd ed. Cambridge: Cambridge University Press 2018
  13. google scholar 13. Tolou-Ghamari Z, Zare M, Habibabadi JM, Najafi MR. A quick review of carbamazepine pharmacokinetics in epilepsy from 1953 to 2012. J Res Med Sci 2013
  14. google scholar 14. Gilman JT. Carbamazepine dosing for pediatric seizure disorders: the highs and lows. DICP 1991
  15. google scholar 15. Chung W H, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC et al. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004
  16. google scholar 16. US Food and Drug Administration. Oxcarbazepine [prescribing information]